![conference banner](/images/conference-banner.jpeg)
Current Molecular Medicine
Title: Editorial [Hot topic: Recent Progress in Cancer Therapeutics (Guest Editor: Kurt S. Zaenker)]
Volume: 10 Issue: 4
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
S. Zaenker Kurt, Editorial [Hot topic: Recent Progress in Cancer Therapeutics (Guest Editor: Kurt S. Zaenker)], Current Molecular Medicine 2010; 10 (4) . https://dx.doi.org/10.2174/156652410791317002
DOI https://dx.doi.org/10.2174/156652410791317002 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
Article Metrics
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Rubber Latex Allergy in Pediatric Patients
Current Pediatric Reviews What Does a Pediatrician Need to Know About Chronic Diarrhea?
Current Pediatric Reviews Antivenoms for Snakebite Envenomings
Inflammation & Allergy - Drug Targets (Discontinued) The Shift in the “Paradigm” of the Pharmacology of Hypertension
Current Topics in Medicinal Chemistry Genetic Engineering of Allergens for Immunotherapy
Inflammation & Allergy - Drug Targets (Discontinued) Kawasaki Disease and Its Treatment – An Update
Current Rheumatology Reviews Allopurinol Hypersensitivity Reactions: Desensitization Strategies and New Therapeutic Alternative Molecules
Inflammation & Allergy - Drug Targets (Discontinued) ADR in Journals: Are They Translated into Regulatory Frameworks?
Current Drug Safety Advances in Inhibitors of FXa
Current Drug Targets Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy
Current Drug Metabolism <i>Spinacia Oleracea</i>: Exploring the Therapeutic Potential in Persian Medicine and Modern Pharmacology
Current Drug Discovery Technologies Small Peptides as Modulators of Serine Proteases
Current Medicinal Chemistry Provocation Tests in Diagnosing Drug Hypersensitivity
Current Pharmaceutical Design The Structure-property Relationships of Clinically Approved Protease Inhibitors
Current Medicinal Chemistry Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Current Pharmaceutical Design Gene Patents in the Primary Prevention of Vascular Diseases
Recent Patents on DNA & Gene Sequences Successful Desensitization of Three Patients with Hypersensitivity Reactions to Omalizumab
Current Drug Safety New Applications for Sublingual Immunotherapy in Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Recent Updates on the Development of Therapeutics for the Targeted Treatment of Alzheimer’s Disease
Current Pharmaceutical Design